| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 1.219 | 13.574 | 21.165 | 7.904 | 0 |
| Total Income - EUR | - | - | - | - | 0 | 3.260 | 27.905 | 25.527 | 10.807 | 2.358 |
| Total Expenses - EUR | - | - | - | - | 2.697 | 21.232 | 31.481 | 31.558 | 11.302 | 2.424 |
| Gross Profit/Loss - EUR | - | - | - | - | -2.697 | -17.973 | -3.576 | -6.030 | -494 | -66 |
| Net Profit/Loss - EUR | - | - | - | - | -2.697 | -17.985 | -3.712 | -6.242 | -574 | -66 |
| Employees | - | - | - | - | 0 | 4 | 4 | 3 | 1 | 0 |
Check the financial reports for the company - Biolarose S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 88 | 19.875 | 14.794 | 10.912 | 7.891 | 5.489 |
| Current Assets | - | - | - | - | 19.956 | 508 | 37.583 | 1.177 | 818 | 671 |
| Inventories | - | - | - | - | 19.685 | 0 | 415 | 397 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 145 | 36.347 | 112 | 309 | 307 |
| Cash | - | - | - | - | 270 | 363 | 821 | 669 | 509 | 364 |
| Shareholders Funds | - | - | - | - | -2.655 | -20.590 | -23.845 | -30.161 | -30.643 | -30.538 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | -7.408 | 6.477 | 6.702 | 12.217 | 12.313 | 12.168 |
| Income in Advance | - | - | - | - | 30.107 | 34.496 | 69.521 | 30.033 | 27.039 | 24.530 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Biolarose S.r.l.